Intralesional sodium stibogluconate alone or its combination with either intramuscular sodium stibogluconate or oral ketoconazole in the treatment of localized cutaneous leishmaniasis: A comparative study

Journal of the European Academy of Dermatology and Venereology

Volumn 24, Issue 3, 2010, Pages 335-340

  El Sayed, M ^a   Anwar, Ae ^a  

^a ZAGAZIG UNIVERSITY   (Egypt)

Author keywords

Cutaneous leishmaniasis; Ketoconazole; Sodium stibogluconate

Indexed keywords

ERYTHROMYCIN; KETOCONAZOLE; RIFAMPICIN; STIBOGLUCONATE SODIUM; ANTIFUNGAL AGENT; ANTIMONY GLUCONATE; ANTIPROTOZOAL AGENT;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION; ARTICLE; CHEEK; CHILD; CLINICAL ARTICLE; COMPARATIVE STUDY; FACE; FEMALE; HUMAN; INJECTION SITE SWELLING; LIP; MALE; PRIORITY JOURNAL; SCHOOL CHILD; SECONDARY INFECTION; SKIN DEFECT; SKIN LEISHMANIASIS; SKIN NODULE; WRIST; CONTROLLED STUDY; DOSE RESPONSE; DRUG COMBINATION; FOLLOW UP; INTRALESIONAL DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; LEISHMANIASIS, CUTANEOUS; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; SKIN; TIME; TREATMENT OUTCOME; YOUNG ADULT;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANTIFUNGAL AGENTS; ANTIMONY SODIUM GLUCONATE; ANTIPROTOZOAL AGENTS; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRALESIONAL; INJECTIONS, INTRAMUSCULAR; KETOCONAZOLE; LEISHMANIASIS, CUTANEOUS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SKIN; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 76349086055     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2009.03417.x     Document Type: Article

References (24)

1. Yanik M, Gurel MS, Simsek Z et al. The psychological impact of cutaneous leishmaniasis. Clin Exp Dermatol 2004 29 : 464 467.
2. Dowlati Y. Cutaneous leishmaniasis clinical aspect. Clin Dermatol 1996 14 : 425 431.
3. Mahajan VK, Sharma NL. Therapeutic options for cutaneous leishmaniasis. J Dermatolog Treat. 2007 18 : 97 104.
4. Tallab TM, Bahamdam KA, Mirdad S et al. Cutaneous leishmaniasis schedules for intralesional treatment with sodium stibogluconate. Int J Dermatol 1996 35 : 594 597.
5. Negi AK, Sharma NL, Mahajan VK et al. Comparative efficacy of intralesional sodium stibogluconate (SSG) alone and its combination with intramuscular SSG to treat localized cutaneous leishmaniasis results of a pilot study. Indian J Dermatol Venereol Leprol. 2007 73 : 280.
6. El Hajj L, Thellier M, Carriere J et al. Localized cutaneous leishmaniasis imported into Paris: a review of 39 cases. Int J Dermatol 2004 43 : 120 125.
7. Grevelink SA, Lerner EA. Leishmaniasis. J Am Acad Dermatol 1996 34 : 257 272.
8. Asilian A, Sadeghinia A, Faghihi G et al. Comparative study of the efficacy of combined cryotherapy and intralesional meglumine antimoniate (Glucantime) vs. cryotherapy and intralesional meglumine antimoniate (Glucantime) alone for the treatment of cutaneous leishmaniasis. Int J Dermatol 2004 43 : 281 283.
9. Mujtaba G, Khalid M. Weekly vs. fortnightly intralesional meglumine antimoniate in cutaneous leishmaniasis. Int J Dermatol 1999 38 : 607 609.
10. Herwaldt BL, Berman JD. Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies. Am J Trop Med Hyg 1992 46 : 296 306.
11. World Health organization. Control of Leishmaniasis. WHO Tech Rep Ser. Organization : Geneva 1990 66 94.
12. Sharma RC, Mahajan VK, Sharma NL et al. A new focus of cutaneous leishmaniasis in Himachal Pradesh (India). Indian J Dermatol Venereol Leprol 2003 69 : 170 172.
13. Sharma NL, Mahajan VK, Kanga A et al. Localized cutaneous leishmaniasis due to Leishmania donovani and Leishmania tropica preliminary findings of the study of 161 new cases from a new endemic focus in himachal pradesh, India. Am J Trop Med Hyg 2005 72 : 819 824.
14. Sharquie KE, Al-Talib KK, Chu AC. Intralesional therapy of cutaneous leishmaniasis with sodium stibogluconate antimony. Br J Dermatol 1988 119 : 53 57.
15. Chulay JD, Spencer HC, Mugambi M. Electrocardiographic changes during treatment of leishmaniasis with pentavalent antimony (sodium stibogluconate). Am J Trop Med Hyg 1985 34 : 702 709.
16. Brummitt CF, Porter JA, Herwaldt BL. Reversible peripheral neuropathy associated with sodium stibogluconate therapy for American cutaneous leishmaniasis. Clin Infect Dis 1996 22 : 878 879.
17. Mallick BK. Hypoplasia of bone marrow secondary to sodium antimony gluconate. J Assoc Physicians India 1990 38 : 310 311.
18. Rai US, Kumar H, Kumar U. Renal dysfunction in patients of kala azar treated with sodium antimony gluconate. J Assoc Physicians India 1994 42 : 383.
19. Berman JD. Human leishmaniasis clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin Infect Dis 1997 24 : 684 703.
20. Kubba R, Al-Gindan Y, El-Hassan AM et al. Ketoconazole in cutaneous leishmaniasis Results of a pilot study. Saudi Med J 1986 7 : 596 604.
21. Bergers M. Mechanisms of antifungal drugs with special reference of imidazole derivatives. Rev Infect Dis 1980 2 : 520 534.
22. Urcuyo FG, Zaias N. Oral ketoconazole in the treatment of leishmaniasis. Int J Dermatol 1982 21 : 414 416.
23. Kumaresan M, Kumar P. Localized cutaneous leishmaniasis in South India successful treatment with ketoconazole. Indian J Dermatol Venereol Leprol 2007 73 : 361 362.
24. DeBeule K, Couwenberg G. The treatment of cutaneous leishmaniasis with ketoconazole and itraconazole. In : Rubinstein E, Adam E, eds. Recent Advances in Chemotherapy, Antimicrobial (Section 2). Lewin-Epstein Ltd, Jerusalem, 1989 : 612.1 612.2.